Almirall, S.A. (VIE:ALM)

Austria flag Austria · Delayed Price · Currency is EUR
12.38
-0.38 (-2.98%)
Last updated: Jan 28, 2026, 3:30 PM CET
31.21%
Market Cap2.76B +46.0%
Revenue (ttm)1.09B +13.8%
Net Income42.05M
EPS0.20
Shares Outn/a
PE Ratio65.59
Forward PE32.51
Dividend0.15 (1.20%)
Ex-Dividend DateMay 15, 2025
Volumen/a
Average Volumen/a
Open12.78
Previous Close12.76
Day's Range12.38 - 12.78
52-Week Range8.68 - 13.60
Betan/a
RSI50.02
Earnings DateFeb 23, 2026

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun... [Read more]

Industry Pharmaceutical Preparations
Founded 1943
Employees 2,084
Stock Exchange Vienna Stock Exchange
Ticker Symbol ALM
Full Company Profile

Financial Performance

Financial Statements